|Last Price$13.52||Day Change (%)0.00%|
|Open Price$13.52||Day Change ($)0.00|
|Day Range13.52–13.52||52-Week Range13.08–13.74|
As of Mon 04/27/2015 | USD
MedDay announces its pivotal Phase III study of MD1003 in patients with Progressive Multiple Sclerosis meets primary endpoint
MedDay provides update on pioneering pivotal Phase III study design in Progressive Multiple Sclerosis
Mid-caps and energy lead the way; growth shows signs of life.